Skip to main content
Premium Trial:

Request an Annual Quote

Quidel Expects Q4 Revenues Above Estimates

NEW YORK (GenomeWeb News) – Quidel today said that it expects to report fourth-quarter revenues of $53 million to $54 million.

That figure is well above Wall Street's consensus estimate for revenues of $43.8 million.

"We saw a sudden and early onset to this year's influenza season," Quidel President and CEO Douglas Bryant said in a statement. "I am pleased, however, with how well we were able to respond to the increased and rapid demand for our flu tests."

He added that in addition to its QuickVue Influenza A+B sales benefitting most from patient visits for influenza-like illness, the firm's Sofia Influenza A+B revenues also were a contributor, with Sofia analyzer placements exceeding internal projections.

In early Friday trade on the Nasdaq shares of Quidel were up 6 percent a $21.24.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.